Caspase3-deficient cells require fibronectin for protection against autophagy-dependent death
Lawrence H. Boise , David B. Weir
bioRxiv
2021
Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo.
Douglas W. Sborov , Alena Cristina Jaime-Ramirez , Benjamin G. Barwick , Enrico Caserta
Molecular Therapy - Oncolytics 20 519 -531
2021
Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple Myeloma
Paula M. Vertino , David L. Jaye , Jonathan J. Keats , Karen N. Conneely
Clinical Cancer Research 27 ( 11) 3178 -3189
2021
A B-Cell like Phenotype Is Associated with Sensitivity to Venetoclax in Multiple Myeloma
Jonathan J. Keats , Shannon Matulis , Benjamin Barwick , Sagar Lonial
Blood 130 3073 -3073
2017
Efficacy of Induction Thearapy with Lenalidomide, Bortezomib, and Dexamethasone (RVD) in 1000 Newly Diagnosed Multiple Myeloma (MM) Patients
Nisha Joseph , Vikas A. Gupta , Craig C Hofmeister , Charise Gleason
Blood 132 3294 -3294
2
2018
Differences in Presentation and Survival Outcomes for African American Patients with Newly Diagnosed Multiple Myeloma
Nisha Joseph , Vikas A. Gupta , Craig C Hofmeister , Charise Gleason
Blood 132 5647 -5647
2
2018
Impact of Early Progression on Long Term Outcomes Among Myeloma Patients Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) Induction Therapy
Ajay K Nooka , Jonathan L Kaufman , Charise Gleason , Nisha Joseph
Blood 132 3302 -3302
2018
Outcomes of Myeloma Patients with t(11;14) Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) Induction Therapy
Jonathan L Kaufman , Nisha Joseph , Vikas A. Gupta , Charise Gleason
Blood 132 3282 -3282
3
2018
Whole Genome DNA Methylation Analysis of Commpass Identifies Biomarkers of Multiple Myeloma Survival
Benjamin G Barwick , Daniel Auclair , Alex Blanski , Meghan Kirchhoff
Blood 132 3174 -3174
2018
Speciation, formation, stability and analytical challenges of human arsenic metabolites
Lucy Yehiayan , Mahesh Pattabiraman , Konstantinos Kavallieratos , Xiaotang Wang
Journal of Analytical Atomic Spectrometry 24 ( 10) 1397 -1405
35
2009
Safety and survival outcomes for bloodless transplantation in patients with myeloma.
Nisha S. Joseph , Jonathan L. Kaufman , Lawrence H. Boise , Kelly Valla
Cancer 125 ( 2) 185 -193
3
2019
Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents
Roberto Mina , Nisha S. Joseph , Jonathan L. Kaufman , Vikas A. Gupta
Cancer 125 ( 3) 416 -423
12
2019
Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refractory patients.
Ajay K. Nooka , Nisha S. Joseph , Jonathan L. Kaufman , Leonard T. Heffner
Cancer 125 ( 17) 2991 -3000
34
2019
Long Term Humoral Immunity Is Dependent on CD28 Expression In Plasma Cells
Cheryl H Rozanski , Ramon Arens , Louise Carlson , Jayakumar Nair
Blood 116 ( 21) 1737 -1737
2010
Targeting the CD28-B7 Pro-Survival Pathway In Multiple Myeloma
Jayakumar Nair , Louise Carlson , Cheryl H Rozanski , Chandana Koorella
Blood 116 ( 21) 132 -132
1
2010
The Combination of Romidepsin and Bortezomib Results in Synergistic Induction of Apoptosis in Human B-Lymphoma Cell Lines.
Deshpande S. Deshpande , Mary Jo Lechowicz , Rajni Sinha , Jonathan L. Kaufman
Blood 114 ( 22) 1689 -1689
2
2009
Determination of multiple human arsenic metabolites employing high performance liquid chromatography inductively coupled plasma mass spectrometry
Szabina Stice , Guangliang Liu , Shannon Matulis , Lawrence H. Boise
Journal of Chromatography B 1009 55 -65
24
2016
Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trials.
Ajay K. Nooka , Jonathan L. Kaufman , Madhusmita Behera , Amelia Langston
Cancer 119 ( 23) 4119 -4128
31
2013
BCL2 dependency in diffuse large B-cell lymphoma: it's a family affair.
Shannon M. Matulis , Lawrence H. Boise
Haematologica 105 ( 8) 1993 -1996
2020
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia.
Adriana E Tron , Matthew A Belmonte , Ammar Adam , Brian M Aquila
Nature Communications 9 ( 1) 5341 -5341
349
2018